Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-065334
Filing Date
2015-11-13
Accepted
2015-11-13 16:06:18
Documents
9
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v423433_10q.htm 10-Q 467716
2 EXHIBIT 31.1 v423433_ex31-1.htm EX-31.1 9613
3 EXHIBIT 32.1 v423433_ex32-1.htm EX-32.1 6437
  Complete submission text file 0001144204-15-065334.txt   3075016

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgrx-20150930.xml EX-101.INS 724378
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20150930.xsd EX-101.SCH 29411
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20150930_cal.xml EX-101.CAL 21306
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20150930_def.xml EX-101.DEF 148717
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20150930_lab.xml EX-101.LAB 190957
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20150930_pre.xml EX-101.PRE 176652
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 151229195
SIC: 2834 Pharmaceutical Preparations